← back to search

Ming He

Hebei Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, RNA modifications and cancer, and Circular RNAs in diseases.
h-index
33
citations
3,931
works
119
NIH funding
primary concept
email

Recent publications

The X-Age Project to construct a Chinese aging clock
Nature Aging 2025cited by 9position: middledoi
Electroacupuncture suppresses motor impairments via microbiota-metabolized LPS/NLRP3 signaling in 6-OHDA induced Parkinson's disease rats
International Immunopharmacology 2025cited by 6position: middledoi
Methyl isoeugenol suppresses NLRP3 inflammasome-mediated pyroptosis via activation of Nrf2/NQO1/HO-1 signaling in cerebral ischemia–reperfusion injury
Biochemical Pharmacology 2025cited by 3position: middledoi
Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study
Frontiers in Immunology 2025cited by 1position: middledoi
Effects of low-density lipoprotein cholesterol on lymph node metastasis after radical esophagectomy
World Journal of Gastrointestinal Surgery 2025cited by 1position: middledoi
Electroacupuncture Ameliorates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease via Gut-Brain Axis Modulation
Research Square 2025cited by 0position: middledoi
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial
BMC Medicine 2023cited by 43position: middledoi
TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets<i>TGFB2</i>and<i>SOX2</i>
Proceedings of the National Academy of Sciences 2022cited by 71position: middledoi
Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching
Frontiers in Immunology 2022cited by 38position: middledoi
The Survival and Prognosis Characteristics of Primary Esophageal Small-Cell Carcinoma
Disease Markers 2022cited by 2position: middledoi
LncRNA XIST promotes metastasis in ESCC by sponging miR-34a to regulate ZEB1 Expression
Research Square 2022cited by 0position: middledoi
JUNB‐FBXO21‐ERK axis promotes cartilage degeneration in osteoarthritis by inhibiting autophagy
Aging Cell 2021cited by 98position: middledoi
An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance
Cell Metabolism 2020cited by 408position: firstdoi
SIRT1 contributes to neuroendocrine differentiation of prostate cancer
Oncotarget 2017cited by 34position: middledoi
miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015cited by 59position: middledoi
Chinese medicine Tongxinluo reduces atherosclerotic lesion by attenuating oxidative stress and inflammation in microvascular endothelial cells.
PubMed 2015cited by 17position: middle
SIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease
Cell Reports 2013cited by 280position: middledoi
Effects of metallothionein-3 and metallothionein-1E gene transfection on proliferation, cell cycle, and apoptosis of esophageal cancer cells
Genetics and Molecular Research 2013cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lining Duan · Guangzhou University of Chinese Medicine3 papers (2025–2025)Linlin Nie · Guangzhou University of Chinese Medicine3 papers (2025–2025)Lixing Zhuang · Guangzhou University of Chinese Medicine3 papers (2025–2025)Yifan Zhang · Guangzhou University of Chinese Medicine3 papers (2025–2025)Shimin Liang · Qingdao University of Science and Technology2 papers (2025–2025)Jingyi Quan · Guangzhou University of Chinese Medicine2 papers (2025–2025)Xiaoxiao Liu · Guangzhou University of Chinese Medicine2 papers (2025–2025)Hanzhi Luo · University of Hong Kong2 papers (2013–2020)Jin‐Kun Wen · Hebei Medical University2 papers (2015–2015)Danica Chen · University of California, Berkeley2 papers (2013–2020)Zhan Yang · Qingdao University2 papers (2015–2015)Lu Zhang · Guangzhou University of Chinese Medicine2 papers (2025–2025)Ruonan Zhang · Shandong University of Traditional Chinese Medicine2 papers (2015–2015)Suying Lei · Guangzhou University of Chinese Medicine1 papers (2025–2025)Xubo Hong · Guangzhou University of Chinese Medicine1 papers (2025–2025)Guanguo Ma · Shaanxi Yulin Energy Group1 papers (2013–2013)Bin Zheng · Beijing University of Civil Engineering and Architecture1 papers (2015–2015)Xiaosong Chen · Guangxi Medical University1 papers (2022–2022)Andrew Murphy · Robert Gordon University1 papers (2013–2013)Zhiming Lin · Sun Yat-sen Memorial Hospital1 papers (2021–2021)